VentriPoint Diagnostics Ltd
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provid… Read more
Market Cap & Net Worth: VentriPoint Diagnostics Ltd (VPTDF)
VentriPoint Diagnostics Ltd (PINK:VPTDF) has a market capitalization of $18.76 Million ($18.76 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #26856 globally and #9047 in its home market, demonstrating a -15.23% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying VentriPoint Diagnostics Ltd's stock price $0.11 by its total outstanding shares 171980967 (171.98 Million).
VentriPoint Diagnostics Ltd Market Cap History: 2025 to 2025
VentriPoint Diagnostics Ltd's market capitalization history from 2025 to 2025. Data shows growth from $18.76 Million to $18.76 Million (0.00% CAGR).
VentriPoint Diagnostics Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how VentriPoint Diagnostics Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of VPTDF by Market Capitalization
Companies near VentriPoint Diagnostics Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to VentriPoint Diagnostics Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
VentriPoint Diagnostics Ltd Historical Marketcap From 2025 to 2025
Between 2025 and today, VentriPoint Diagnostics Ltd's market cap moved from $18.76 Million to $ 18.76 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $18.76 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of VentriPoint Diagnostics Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $18.76 Million USD |
| MoneyControl | $18.76 Million USD |
| MarketWatch | $18.76 Million USD |
| marketcap.company | $18.76 Million USD |
| Reuters | $18.76 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.